candidates for glp-1 Novo Nordisk vs Eli Lilly: Who's Winning the Obesity Drug Race? GLP-1 Medications for Weight Loss:

I'm sharing my favorite low-calorie coffee and drink hacks that fit perfectly with my weight loss journey

See our four medically vetted mag glycinate picks and get expert answers to FAQ.

Recent Findings Emerging evidence suggests that GLP-1R agonists have a role in pediatric obesity treatment

Ads from Pfizer (for cancer and innovation awareness), Bayer (for heart health), and my personal favorite, Novartis for womens health and promoting the call-to-action for breast cancer screening, added info-tainment to the ad watching see #YourAttentionPlease to track this wonderful health education/literacy promotion for public health

All of these unanswered questions only add to the urgency of determining who is most likely to benefit from GLP-1s. : Luliia Burmistrova / Getty

Over the past year, conversations about GLP-1 have exploded, thanks in large part to injectable drugs like Ozempic and Wegovy